Tess Burleson

Tess Burleson, listed as board member, appears in our data through filings on Salarius Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 11 February 2020 and 3 January 2023, the trades on record add up to 3 filings.

On the market, this insider has only ever bought: 2 purchases, €9,244 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.

On 5 January 2023 came the latest disclosure, a share grant in Salarius Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,599 days ago, on 8 June 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.